Search clinical trials for: Bortezomib (Velcade®)
Total 14663 results
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Intergroupe Francophone du MyelomeCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium Pharmaceuticals, Inc.CompletedRefractory Acute Leukemia | Relapsed Acute LeukemiaUnited States
-
The First Affiliated Hospital of Soochow UniversityUnknownMultiple Myeloma Proved by Laboratory TestsChina
-
Louisiana State University Health Sciences Center...Millennium Pharmaceuticals, Inc.WithdrawnFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone LymphomaUnited States
-
E. Steve WoodleGlaxoSmithKlineCompleted
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminated
-
Reuven SchoreMillennium Pharmaceuticals, Inc.; Hyundai Hope On WheelsTerminated
-
Dana-Farber Cancer InstituteNovartis; Millennium Pharmaceuticals, Inc.TerminatedWaldenstrom's MacroglobulinemiaUnited States
-
AmgenCompletedLymphoma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large Cell Lymphoma | Low Grade Lymphoma
-
European Myeloma NetworkUniversitaire Ziekenhuizen KU Leuven; University of Roma La Sapienza; Hospital... and other collaboratorsCompletedWaldenstroms MacroglobulinemiaGreece
-
Gilead SciencesCompletedHepatitis C VirusUnited States, Puerto Rico
-
City of Hope Medical CenterCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Pierluigi PorcuMillennium Pharmaceuticals, Inc.; Celgene CorporationCompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Post-transplant Lymphoproliferative Disorder | Recurrent Adult T-cell Leukemia/Lymphoma | Recurrent Cutaneous T-cell... and other conditionsUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Nasopharyngeal Cancer | Stage IV Nasopharyngeal CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaCelgene Corporation; Janssen-Cilag Ltd.UnknownMultiple MyelomaAustralia
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsCompleted
-
University Hospital FreiburgMerck Sharp & Dohme LLC; Janssen-Cilag Ltd.Completed
-
NCIC Clinical Trials GroupCompleted
-
University Hospital, Clermont-FerrandLaboratoires TakedaUnknownMultiple Myeloma | Adult | Bortezomib RegimenFrance
-
Janssen-Cilag International NVCompletedMultiple MyelomaTurkey, Greece, Czech Republic, Austria, Germany, Sweden, United Kingdom, Denmark
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.CompletedMultiple MyelomaNorway, Sweden, Denmark, Finland, Iceland
-
Nantes University HospitalCompleted
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
European Myeloma NetworkCompletedMultiple Myeloma | Hematologic MalignanciesSpain, Sweden, Germany, Italy
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, France, Spain, Israel, India, Romania, Korea, Republic of, Singapore, Russian Federation, Poland
-
Chinese SLE Treatment And Research GroupRecruiting
-
Weill Medical College of Cornell UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
Indiana UniversityCompleted
-
National Cancer Institute (NCI)TerminatedGastrointestinal Cancer | Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder... and other conditionsUnited States
-
International Extranodal Lymphoma Study Group (IELSG)TerminatedLymphoma, Mucosa-Associated Lymphoid TissueSwitzerland
-
Janssen Korea, Ltd., KoreaCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
University of WuerzburgUnknownMultiple MyelomaAustria, Germany, Italy
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
Giselle ShollerBeat NB Cancer Foundation; Because of Ezra; K C Pharmaceuticals Inc.CompletedNeuroblastoma RecurrentUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Terminated